Cargando…

Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease

Detalles Bibliográficos
Autores principales:	Liaudet, Lucas, Szabo, Csaba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278213/ https://www.ncbi.nlm.nih.gov/pubmed/32513242 http://dx.doi.org/10.1186/s13054-020-03055-6

Ejemplares similares

Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and Physiology
por: Pereira, Sofia S., et al.
Publicado: (2021)

Efficacy of mineralocorticoid receptor antagonism in the acute myocardial infarction phase: eplerenone versus spironolactone
por: Fraccarollo, Daniela, et al.
Publicado: (2015)

PS135. Effects of the mineralocorticoid receptor antagonist spironolactone in a treatment-resistant model of depression in female rats
por: Hlavacova, N, et al.
Publicado: (2016)

The Time to Reconsider Mineralocorticoid Receptor Blocking Strategy: Arrival of Nonsteroidal Mineralocorticoid Receptor Blockers
por: Tezuka, Yuta, et al.
Publicado: (2022)

Blocking Mineralocorticoid Receptors Impairs, Blocking Glucocorticoid Receptors Enhances Memory Retrieval in Humans
por: Rimmele, Ulrike, et al.
Publicado: (2013)

Poly(ADP-Ribose) Polymerase Inhibition in Acute Lung Injury. A Reemerging Concept
por: Szabo, Csaba, et al.
Publicado: (2020)

Therapeutic Efficacy of Spironolactone for Central Serous Chorioretinopathy
por: Han, Jae Yong, et al.
Publicado: (2022)

Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014)

Blocking Mineralocorticoid Receptors prior to Retrieval Reduces Contextual Fear Memory in Mice
por: Zhou, Ming, et al.
Publicado: (2011)

Blocking the Mineralocorticoid Receptor Improves Cognitive Impairment after Anesthesia/Splenectomy in Rats
por: Feng, Xixia, et al.
Publicado: (2021)

Expression of genes encoding mineralocorticoid biosynthetic enzymes and the mineralocorticoid receptor, and levels of mineralocorticoids in the bovine follicle and corpus luteum
por: MUKANGWA, Memory, et al.
Publicado: (2019)

Cell-specific mineralocorticoid receptors: future therapeutic targets for stroke?
por: Dinh, Quynh N., et al.
Publicado: (2016)

Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction
por: Enzan, Nobuyuki, et al.
Publicado: (2020)

Higher Physical Activity Levels in Children Have Wide Ranging Benefits: Towards Multisectoral Action
por: Goenka, Shifalika, et al.
Publicado: (2020)

One Hormone for Two Receptors: Exploring Glucocorticoid Actions Mediated by the Glucocorticoid and Mineralocorticoid Receptors
por: Petrillo, Maria G, et al.
Publicado: (2021)

30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development
por: Kolkhof, Peter, et al.
Publicado: (2017)

Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
por: Tesch, Greg H., et al.
Publicado: (2017)

Mineralocorticoid receptor blockade for renoprotection
por: Cha, Dae Ryong
Publicado: (2018)

Heterogeneous natural history of Addison’s disease: mineralocorticoid deficiency may predominate
por: Howarth, Sophie, et al.
Publicado: (2022)

Importance of Micromilieu for Pathophysiologic Mineralocorticoid Receptor Activity—When the Mineralocorticoid Receptor Resides in the Wrong Neighborhood
por: Griesler, Bruno, et al.
Publicado: (2022)

Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor Antagonists
por: Mende, Christian W., et al.
Publicado: (2023)

Principal function of mineralocorticoid signaling suggested by constitutive knockout of the mineralocorticoid receptor in medaka fish
por: Sakamoto, Tatsuya, et al.
Publicado: (2016)

Spironolactone-Induced Unilateral Gynecomastia
por: Veeregowda, Sahana Hadihalli, et al.
Publicado: (2018)

Mineralocorticoid hypertension
por: Gupta, Vishal
Publicado: (2011)

The Cardiac Mineralocorticoid Receptor (MR): A Therapeutic Target Against Ventricular Arrhythmias
por: Rossier, Michel F.
Publicado: (2021)

Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research
por: Mamazhakypov, Argen, et al.
Publicado: (2023)

The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone
por: Bamberg, Krister, et al.
Publicado: (2019)

Combinatorial actions of glucocorticoid and mineralocorticoid stress hormone receptors are required for preventing neurodegeneration of the mouse hippocampus
por: Oakley, Robert H., et al.
Publicado: (2021)

Why are mineralocorticoid receptor antagonists cardioprotective?
por: Chai, Wenxia, et al.
Publicado: (2006)

Localization of Mineralocorticoid Receptors at Mammalian Synapses
por: Prager, Eric M., et al.
Publicado: (2010)

Aldosterone and Mineralocorticoid Receptors—Physiology and Pathophysiology
por: Funder, John W.
Publicado: (2017)

Temporal variation may have diverse impacts on range limits
por: Holt, Robert D., et al.
Publicado: (2022)

Effect of spironolactone on pain responses in mice
por: Abdel-Salam, Omar M.E., et al.
Publicado: (2010)

Spironolactone in cardiovascular disease: an expanding universe?
por: Funder, John W.
Publicado: (2017)

Imatinib and spironolactone suppress hepcidin expression
por: Mleczko-Sanecka, Katarzyna, et al.
Publicado: (2017)

Furosemide/spironolactone: Hypotension: case report
Publicado: (2022)

Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease
por: Folkerts, Kerstin, et al.
Publicado: (2022)

Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke
por: Dinh, Quynh N, et al.
Publicado: (2012)

Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone
por: Muñoz-Durango, N., et al.
Publicado: (2015)

Mineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and Atherosclerosis
por: Moss, Mary E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_205d7nena8misclhbeg803so16